Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $50.39 in the prior trading day, Corcept Therapeutics Inc (NASDAQ: CORT) closed at $49.97, down -0.83%. In other words, the price has decreased by -$0.83 from its previous closing price. On the day, 0.84 million shares were traded. CORT stock price reached its highest trading level at $51.91 during the session, while it also had its lowest trading level at $49.42.
Ratios:
Our goal is to gain a better understanding of CORT by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 36.72. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 02 ’25 when Maduck Sean bought 20,000 shares for $50.39 per share.
Robb Gary Charles bought 11,000 shares of CORT for $554,986 on Jan 02 ’25. On Jan 02 ’25, another insider, Lyon Joseph Douglas, who serves as the Officer of the company, bought 5,000 shares for $50.34 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORT now has a Market Capitalization of 5235607040 and an Enterprise Value of 4862068736. As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 39.74, and their Forward P/E ratio for the next fiscal year is 26.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.33 while its Price-to-Book (P/B) ratio in mrq is 8.19. Its current Enterprise Value per Revenue stands at 7.735 whereas that against EBITDA is 33.744.
Stock Price History:
Over the past 52 weeks, CORT has reached a high of $62.22, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -7.73%, while the 200-Day Moving Average is calculated to be 31.48%.
Shares Statistics:
The stock has traded on average 973.99K shares per day over the past 3-months and 855180 shares per day over the last 10 days, according to various share statistics. A total of 104.70M shares are outstanding, with a floating share count of 90.24M. Insiders hold about 13.87% of the company’s shares, while institutions hold 82.22% stake in the company. Shares short for CORT as of 1734048000 were 15715773 with a Short Ratio of 16.14, compared to 1731628800 on 18344291. Therefore, it implies a Short% of Shares Outstanding of 15715773 and a Short% of Float of 21.059998999999998.
